NewLink Genetics Corp. (NASDAQ:NLNK) has reported EPS of $(0.72) for its last quarter. For the ongoing quarter, market analysts are anticipating EPS to come to $-0.71.
The EPS that NewLink Genetics Corp. has announced for the recent quarter stemmed from sales of 2.76M%, which grew -1.07% from the same period, a year ago. The sales growth increased/dropped by decline%.
Let’s look into the technical of the stock
The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend. The market is in highly oversold territory. Beware of a trend reversal.
Because, company incurred other costs in the course of its businesses, deducting from the gross profit and dividing the variance by the number of shares due yielded the recorded revenue of $(0.72). Investors should bear in mind that NewLink Genetics Corp. closed the last quarter with diluted shares due amounting to 29.21M.
NewLink Genetics Corp.’s debt exiting the last quarter amounted to 234,000%, indicating that the debt grew/declined by falling from the preceding period.
What is NewLink Genetics Corp.’s liquidity position and can it continue funding its businesses? The firm closed the previous quarter with cash balance of 118.24M%, having posted free cash flow of $(13.04M) during the last quarter. Net cash flow from businesses during the quarter was $(13.01M), resulting in net change in cash of $(13.25M).
What about the performance of the firm?s balance sheet? NewLink Genetics Corp. had total assets of $149.62M at the end of the recent quarter, whereas total liabilities amounted to $35.27M.
As for the Wall Street sentiment pertaining the stock, some 5 analysts have remarked on NewLink Genetics Corp. so far, giving it an average recommendation of Overweight. Investors should understand that a call of 1 up to 1.24 implies the stock is a BUY, whereas recommendation of 2.75 up to 3.00 implies a stock is a SELL.
Investors in NewLink Genetics Corporation NLNK need to pay close attention to the stock based on moves in the options market lately. That is because the June 16th, 2017 $13 Put had some of the highest implied volatility of all equity options today.